Anxiety disorders Pharmaceuticals Self-awareness 
Mad in America
NOVEMBER 27, 2024
While expanding trauma criteria is often justified as necessary for inclusivity and compassion, critics contend that these expansions may be driven, by some, out of self-interest. It increased demand for therapy and medication, amplified the importance and influence of experts within the field and justified allocating more resources to it.
Mad in America
OCTOBER 25, 2023
I’m diagnosing a depressive and anxiety disorder and recommending medication.” So I just thought that maybe I needed to change pharmaceuticals, not change who I was and my perspective. I think radical acceptance and radical self-awareness go hand in hand.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
FEBRUARY 5, 2024
One of these studies, sponsored of course by a pharmaceutical company, was conducted by the Kansas University Medical School, Wichita branch, and I attended, along with a group of local psychologists, a presentation of this study in progress by one of the staff psychologists who was one of the researchers and CBT therapists.
Mad in America
DECEMBER 25, 2023
These drugs have often become the sole treatment for a variety of behavioral health disorders including clinical depression, anxiety disorders, obsessive compulsive disorder, and other approved and off-label uses of these drugs. How can one account for such an enormous increase in the prevalence of the disorder?
Mad in America
FEBRUARY 1, 2025
R egardless of the context and cause, distress is increasingly interpreted and diagnosed as a mental illnesscommonly clinical depression and/or anxiety disorder. These international campaigns helped lead to the development of the National Depression Awareness Campaign, launched in 1994 by the Mental Health Foundation of Australia.
Expert insights. Personalized for you.
141 
Let's personalize your content